<scp>KT</scp> ‐939: A Next‐Generation Human Tyrosinase Inhibitor With Superior Efficacy for the Safe Management of Hyperpigmentation
KT-939 is a potent and safe human tyrosinase inhibitor with additional antioxidant and anti-inflammatory activity. These findings support its potential in cosmetic skin brightening and as a therapeutic candidate for hyperpigmentation disorders.
Authors
- Y. Li (ORCID: https://orcid.org/0009-0001-1394-8066)
- Yueying Yang (ORCID: https://orcid.org/0000-0003-4808-4947)
- Andy Goren (ORCID: https://orcid.org/0000-0002-8190-2289)
- Youzhi Tong
- Xiaodan Hou
- Nina Mehta (ORCID: https://orcid.org/0000-0001-7745-9993)
- Xiaoxiao Cai (ORCID: https://orcid.org/0000-0002-5654-7414)
- Min Ding (ORCID: https://orcid.org/0000-0002-6197-5376)
- Dong Chen (ORCID: https://orcid.org/0000-0003-1198-6058)
- Jie Chen (ORCID: https://orcid.org/0000-0003-1945-0047)
- Jinfeng Wang (ORCID: https://orcid.org/0000-0002-6687-9420)
- Qun Zhang (ORCID: https://orcid.org/0000-0003-3590-757X)
- Xin Zhang (ORCID: https://orcid.org/0000-0001-6036-2685)
- Honghua Yan
Institutions
- University of North Carolina at Chapel Hill (US)
- Marconi University (IT)
- Jiangsu Nhwa Pharmaceutical (China) (CN)
Publication Details
- Journal
- Journal of Cosmetic Dermatology
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1111/jocd.70510
- Primary Topic
- melanin and skin pigmentation
- Type
- article
- Field-Weighted Citation Impact
- 0.00